Abeona Therapeutics Inc (ABEO) has risen 12.65% in a Week, Should You Hold?

Abeona Therapeutics Inc (ABEO) is near the top in its industry group according to InvestorsObserver. ABEO gets an overall rating of 80. That means it scores higher than 80 percent of stocks. Abeona Therapeutics Inc gets a 96 rank in the Biotechnology industry. Biotechnology is number 53 out of 148 industries.

ABEO has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on ABEO!

See Full ABEO Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 80 means the stock is more attractive than 80 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Abeona Therapeutics Inc Stock Today?

Abeona Therapeutics Inc (ABEO) stock has risen 9.51% while the S&P 500 is down -0.21% as of 9:39 AM on Monday, Nov 27. ABEO is up $0.41 from the previous closing price of $4.31 on volume of 212,999 shares. Over the past year the S&P 500 has risen 14.77% while ABEO is up 22.28%. ABEO lost -$2.02 per share the over the last 12 months. Click Here to get the full Stock Report for Abeona Therapeutics Inc stock.